Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 49 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 9375424

    Compounds that treat malaria and prevent malaria transmission

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted

  2. US 9370559

    Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1

    The United States of America, as represented by the Secretary, Department of Heath Services · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted

  3. US 9364448

    Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted

  4. US 9364557

    Fold-back diabody diphtheria toxin immunotoxin and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted

  5. US 9365626

    Simukunin

    The United States of America as represented by the Secretary of the Dept. of Health & Human Services · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted

  6. US 9359447

    Anti-mesothelin chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  7. US 9358306

    Photosensitizing antibody-fluorophore conjugates

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  8. US 9358285

    Granulysin in immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  9. US 9359418

    Inhibitors of the T cell-specific alternative p38 activation pathway and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  10. US 9353117

    Substituted pyrazolopyrimidines as glucocerebrosidase activators

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted May 31, 2016 · Expires May 26, 2036

    granted

  11. US 9353353

    Virus-like particles (VLPs) prepared from chikungunya virus structural proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 31, 2016 · Expires May 26, 2036

    granted

  12. US 9352032

    Live attenuated antigenically marked classical swine fever vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted May 31, 2016 · Expires May 26, 2036

    granted

  13. US 9347951

    Fusion protein comprising the extracellular domain of a filovirus glycoprotein fused to an immunoglobulin heavy chain constant region

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted May 24, 2016 · Expires May 19, 2036

    granted

  14. US 9346875

    Therapy for filovirus infection

    The United States of America as represented by the Secretary of the Army · Granted May 24, 2016 · Expires May 19, 2036

    granted

  15. US 9345758

    Materials and methods for respiratory disease control in canines

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted May 24, 2016 · Expires May 19, 2036

    granted

  16. US 9345748

    Anti-SSX-2 T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 24, 2016 · Expires May 19, 2036

    granted

  17. US 9346859

    Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 24, 2016 · Expires May 19, 2036

    granted

  18. US 9341619

    Hyposialylation disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 17, 2016 · Expires May 12, 2036

    granted

  19. US 9334522

    Agents and methods to elicit anti-tumor immune response

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 10, 2016 · Expires May 5, 2036

    granted

  20. US 9333237

    Bone morphogenic protein binding peptide

    The United States of America National Institutes of Health (NIH), U.S. Dept of Health and Human Services (DHHS) · Granted May 10, 2016 · Expires May 5, 2036

    granted

  21. US 9333251

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 10, 2016 · Expires May 5, 2036

    granted

  22. US 9334246

    Substituted triazines for malaria treatment and chemoprophylaxis

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted May 10, 2016 · Expires May 5, 2036

    granted

  23. US 9326978

    A3 adenosine receptor allosteric modulators

    THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPT. HEALTH & HUMAN SERVICES · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  24. US 9326992

    Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.